Published in
Ferrata Storti Foundation, Haematologica, 2(102), p. 327-335
DOI: 10.3324/haematol.2016.151126
Links
Tools
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis
Journal article published in 2016 by
John O. Mascarenhas,
Moshe Talpaz,
Vikas Gupta 
,
Lynda M. Foltz,
Michael R. Savona,
Ronald Paquette,
A. Robert Turner,
Paul Coughlin,
Elliott Winton,
Timothy C. Burn,
Peter O’Neill,
Jason Clark,
Deborah Hunter,
Albert Assad,
Ronald Hoffman
and other authors.
,
Lynda M. Foltz,
Michael R. Savona,
Ronald Paquette,
A. Robert Turner,
Paul Coughlin,
Elliott Winton,
Timothy C. Burn,
Peter O’Neill,
Jason Clark,
Deborah Hunter,
Albert Assad,
Ronald Hoffman
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 